Mazen Abu‐Mugheisib
Mazen Abu‐Mugheisib publishes mostly in Neurology, Pathology and Forensic Medicine and Epidemiology, on topics such as Multiple Sclerosis Research Studies, Acute Ischemic Stroke Management and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #3,080,696 of 7,710,434 ranked researchers
- Rank in Germany
- #153,312 of 364,343
- Works
- 19
- Citations
- 655
- Citations per work
- 34.5
What does Mazen Abu‐Mugheisib research?
Mazen Abu‐Mugheisib's work is mostly in Medicine (74%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1473.6%
- Medicine1473.6%
- Everything else526.4%
- 1Neurology26% of their works
- 2Pathology and Forensic Medicine17% of their works
- 3Epidemiology9% of their works
- 4Rehabilitation9% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- Multiple Sclerosis Research Studies
- Acute Ischemic Stroke Management
- Botulinum Toxin and Related Neurological Disorders
- Stroke Rehabilitation and Recovery
- Telemedicine and Telehealth Implementation
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Peripheral Neuropathies and Disorders
Which keywords describe Mazen Abu‐Mugheisib's research?
The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Neurological Disorders, Neuromyelitis Optica, Treatment, Ischemic Stroke, Thrombolysis and Botulinum Toxin.
- a-Synuclein
- Neurodegeneration
- Deep Brain Stimulation
- Telemedicine
- Parkinson's Disease
- Neural Plasticity
- Botulinum Toxin
- Ischemic Stroke
- Neuromyelitis Optica
- Multiple Sclerosis
- Diagnostic Criteria
- Neurological Disorders
- Treatment
- Thrombolysis
- Motor Recovery
- Neurotoxins
- Telehealth
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Guillain-Barré Syndrome
- Subthalamic Nucleus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Diagnostic Criteria102 topics
- Multiple Sclerosis81 topic
- Neurological Disorders83 topics
- Neuromyelitis Optica81 topic
- Treatment62 topics
- Ischemic Stroke51 topic
- Thrombolysis51 topic
- Botulinum Toxin41 topic
- Motor Recovery41 topic
- Neural Plasticity41 topic
- Neurotoxins41 topic
- Parkinson's Disease42 topics
- Telehealth31 topic
- Telemedicine31 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy21 topic
- Deep Brain Stimulation21 topic
- Guillain-Barré Syndrome21 topic
- Neurodegeneration21 topic
- Subthalamic Nucleus21 topic
- a-Synuclein21 topic
Where does Mazen Abu‐Mugheisib work?
Mazen Abu‐Mugheisib's main affiliation in the publication record is Klinikum Braunschweig, Germany.
How many publications and citations does Mazen Abu‐Mugheisib have?
OpenAlex counts 19 works and 655 citations for Mazen Abu‐Mugheisib, an h-index of 10, ranking #3,080,696 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mazen Abu‐Mugheisib. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.